Posted by Michael Wonder on 23 Apr 2019
Canadians will wait longer for new medicines if Health Canada gets its way
23 April 2019 - The intention is to lower prices; the net result will likely be longer wait times before new drugs are introduced.
The Canadian government is planning to change the way prices are set for new patented drugs and cut the maximum prices at which these drugs can be sold by up to 70%.
But this reform could prove very costly for patients. If it goes forward and fails to take into account the adverse effects of reference pricing systems, which have been well documented by various international bodies, Canadians could see their access to new drugs slowed down or even compromised.
